It has been shown that p38 MAPK inhibits the JNK pathway through induction of the phosphatase DUSP1 [44], which along with DUSP6, was recently reported to control the activity of ERK in CLL cells. Here, MAPK1 is linked to B-cell chronic lymphocytic leukemia.